Development and evaluation of controlled release products with emerging technologies

American Pharmaceutical Review

Volumn 12, Issue 6, 2009, Pages 147-149

  Marroum, Patrick ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DRUG SCREENING; MAXIMUM PLASMA CONCENTRATION; PHARMACEUTICS; SHORT SURVEY; STEADY STATE;

EID: 70350607871     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (4)

1. Guidance for providing clinical evidence of effectiveness for human drug and biological products. Center for Drug Evaluation and Research, Food and Drug Administration May 1998
2. Code of Federal Regulations 21 320.25
3. Code of Federal Regulations 21 314.54
4. H Malinowski, P Marroum, R Uppoor et al, FDA guidance for industry, extended release solid oral dosage forms: development, evaluation and applications of in vivo in vitro correlation. Diss Tech 4:23-32. 1997